Axsome reports third-quarter 2026 results, starts Phase 3 smoking cessation trialNov 2Quarterly updateAxsome Therapeutics, Inc.dextromethorphan-bupropion
Lilly posts two DC-806 Phase 1 DDI results; registers three new Phase 3 trialsOct 22Weekly roundup, 11 itemscetuximabdulaglutide
Sign inSign in